How much does Ozempic cost in the UK?

Ozempic is the brand name for once-weekly semaglutide injection pens licensed for type 2 diabetes.

On the NHS, it can be prescribed when it is an appropriate option under NICE guidance for type 2 diabetes - typically when other glucose-lowering treatments have not achieved adequate control, or when there are reasons to prefer a GLP-1 receptor agonist.

If you receive Ozempic on an NHS prescription, you do not pay the commercial price of the medicine. What you pay depends on where you live:

• England: the standard NHS prescription charge, currently around £9.90 per item. Crucially, most people who use medication to treat diabetes are entitled to a medical exemption certificate, which makes all their NHS prescriptions free - ask your GP surgery for the FP92A application form if you do not already have one.
• Scotland, Wales and Northern Ireland: NHS prescriptions are free for everyone.

If you pay for several prescriptions in England and do not qualify for exemption, a prescription prepayment certificate (PPC) caps your annual cost regardless of how many items you collect.

The NHS itself pays the manufacturer's list price, which is roughly £73-75 per pen (a four-week supply) depending on strength - useful context when comparing private offers.

Supply of Ozempic has been constrained at times in recent years, and prescribers have been asked to prioritise existing diabetes patients; your pharmacist can advise if a particular pen strength is temporarily hard to obtain.

Outside the NHS, Ozempic can be prescribed privately - but only where it is clinically appropriate, which for Ozempic's licence means type 2 diabetes.

Some private prescribers also issue off-label prescriptions for weight management, although regulators and professional bodies have urged restraint, particularly during supply shortages.

Typical private costs in the UK are around £150-250 per month, made up of several elements:

• The medicine itself. Private pharmacies buy at commercial prices and add a margin, so a single pen commonly costs £120-200 depending on strength (0.25 mg, 0.5 mg, 1 mg or 2 mg weekly doses).
• Consultation or service fees. Online clinics may charge £20-50 for an initial assessment, or build the fee into a monthly subscription.
• Dose escalation. Treatment starts at 0.25 mg weekly and usually steps up over several months. Higher-strength pens often cost more, so your monthly outlay can rise as your dose increases.
• Extras such as needles and sharps disposal, though these are often included.

Prices vary noticeably between providers, so it is worth comparing - but only among legitimate, UK-registered services.

A genuine private prescription always involves a prescriber assessing your medical history, and the pharmacy dispensing it must be registered with the General Pharmaceutical Council (GPhC).

Be wary of any service that asks no medical questions, promises delivery without a prescription, or undercuts every competitor by a wide margin: with Ozempic, a price that looks too good to be true almost always is.

A common source of confusion is the difference between Ozempic and Wegovy. Both contain semaglutide and are made by the same manufacturer, but they are licensed for different conditions:

• Ozempic is licensed for type 2 diabetes, in doses up to 2 mg weekly.
• Wegovy is licensed for weight management, in doses up to 2.4 mg weekly.

On the NHS, semaglutide for weight loss is provided as Wegovy, and NICE guidance attaches conditions: it is recommended for adults meeting specific BMI and weight-related health criteria, usually alongside diet and physical activity support, and historically through specialist weight management services.

Access arrangements have been evolving, but the principle remains that the NHS funds semaglutide for weight loss only under its weight-loss licence and NICE criteria - not as Ozempic prescribed off-label.

This distinction matters financially.

If you do not have type 2 diabetes, you cannot expect an NHS prescription for Ozempic, and a GP who declines to prescribe it for weight loss is following national guidance rather than being obstructive.

• asking your GP whether you meet criteria for NHS weight management services, which may include Wegovy or other medicines such as tirzepatide (Mounjaro) where commissioned
• a private prescription for a weight-loss-licensed medicine, with the monthly costs described above
• evidence-based non-drug approaches, which remain the foundation of any weight management plan.

During earlier supply shortages, UK authorities explicitly asked prescribers not to start Ozempic off-label for weight loss so that people with diabetes would not run out - another reason this route has narrowed.

If you are paying privately, several factors explain why quoted Ozempic prices differ so much between providers and over time:

• Pen strength and dose. Pens are priced per device, and one pen covers four weekly doses at your prescribed level. As you titrate from 0.25 mg up to 1 mg or 2 mg weekly, you may move to more expensive pens, so a £150 starting price can become £200-250 at maintenance doses.
• Supply and demand. Global demand for GLP-1 medicines has periodically outstripped manufacturing capacity. During shortages, private prices tend to rise and some pharmacies limit new patients or specific strengths.
• Provider business model. Online subscription services bundle prescriber reviews, apps and support into a monthly fee; a local pharmacy dispensing a private prescription from your own GP may simply charge the medicine cost plus a dispensing fee. Neither model is automatically cheaper - compare the total monthly cost.
• Consultation and follow-up fees. Reputable services include clinical follow-up, which has genuine value: dose changes, side-effect management and blood test advice should not be optional extras.
• Geography and competition. Prices in large cities with many competing pharmacies are often keener than in areas with little competition.

When comparing offers, ask each provider for the all-in monthly price at your current dose, whether follow-up consultations cost extra, and what happens to the price as your dose increases.

Legitimate providers answer these questions readily; evasiveness about pricing is itself a warning sign.

High demand and high prices have made Ozempic a prime target for criminals.

The MHRA has issued repeated warnings after seizing counterfeit Ozempic pens from the UK supply chain and from online sellers.

Some fake pens recovered in the UK and Europe were found to contain insulin instead of semaglutide, and people who used them suffered hypoglycaemic episodes - dangerously low blood sugar that can cause seizures, coma and death.

Protect yourself with a few firm rules:

• Only obtain Ozempic with a valid prescription from a UK-registered prescriber, dispensed by a pharmacy registered with the GPhC (you can check the register online). This applies equally to online pharmacies, which must display their registration details.
• Never buy weight-loss or diabetes injections from social media, beauty salons, gyms or unregulated websites. These channels are where counterfeit and unlicensed pens circulate.
• Be suspicious of prices far below the market. Genuine semaglutide costs pharmacies a substantial amount; an offer at £50-80 per pen with no prescription requirement is effectively an admission that the product is illegitimate.
• Check the product on arrival. Genuine pens come in manufacturer packaging with an information leaflet, batch number and expiry date, and UK packs are labelled in English. Poor printing, missing leaflets or unusual pen designs are red flags.

If you suspect you have received a fake pen, do not use it.

Report it to the MHRA via its Yellow Card scheme, which accepts reports on suspected counterfeit medicines as well as side effects, and tell the pharmacy or seller's regulator.

A bargain that puts insulin of unknown dose into your body is no bargain at all.

There are legitimate ways to manage the cost of semaglutide treatment - and some false economies to avoid.

If you have type 2 diabetes, start by making sure you are not overpaying for NHS care: apply for a medical exemption certificate in England if you take diabetes medication, or use a prescription prepayment certificate if you pay for multiple items.

These routes make NHS Ozempic either free or far cheaper than any private alternative.

If you are paying privately, sensible steps include:

• Compare registered providers on the all-in monthly cost at your dose, including consultations and delivery.
• Ask about treatment reviews. If Ozempic is not delivering meaningful benefit after an agreed period, continuing to pay monthly makes little sense; a structured review protects both your health and your wallet.
• Discuss alternatives with a clinician. Depending on your situation, other options - different GLP-1 medicines, older diabetes drugs such as metformin, or NHS weight management referral - may achieve similar goals at far lower cost.

What you should not do to save money:

• Do not stretch doses by injecting less than prescribed or skipping weeks; erratic dosing undermines the treatment effect and wastes what you do spend.
• Do not share pens with anyone, even with a fresh needle - pen-sharing risks transmitting blood-borne infections.
• Do not switch to unregulated sellers, compounded products or imports of unknown provenance to chase a lower price.

If cost is forcing difficult choices, tell your GP or prescriber honestly. They would far rather adjust your treatment plan than discover you have been rationing doses or buying from unsafe sources.